Advertisement
Home Tags Vaccines

Tag: Vaccines

FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday

0

Agency also expected to reduce the amount of time adolescents and adults must wait between their second dose of vaccine and booster

No Effect on Ovarian Reserve Seen After mRNA COVID-19 Vaccination

0

Mean levels of anti-Müllerian hormone unchanged from baseline to three months after vaccination among reproductive-aged women

Vaccinated Kidney Transplant Recipients Vulnerable to SARS-CoV-2 Variants

0

After two-dose vaccination, only 64 and 67 percent of kidney transplant recipients showed neutralization against B.1.351 (β) and B.1.617.2 (δ)

Breakthrough COVID-19 Infection Risk Higher With Immune Dysfunction

0

Risk for breakthrough infection higher for those with immunocompromising conditions, such as HIV, rheumatoid arthritis, solid organ transplant

Cancer Patients With Breakthrough COVID-19 Remain at Risk for Severe Outcomes

0

No significant difference observed in 30-day mortality for fully vaccinated versus unvaccinated cancer patients with COVID-19

NVX-CoV2373 Vaccine Protects Against COVID-19

0

Study conducted in the U.S. and Mexico shows vaccine 90 percent effective overall, 100 percent effective against moderate-to-severe disease

mRNA COVID-19 Vaccine Less Protective in Elderly With Comorbidity

0

At ≥7 days after second dose, effectiveness of mRNA COVID-19 vaccine was 69 percent against infection, 86 percent against related death

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...

COVID-19 Certification Mandates May Increase Vaccine Uptake

0

Country-specific information, such as prior vaccination uptake, vaccine hesitancy may influence the effect of COVID-19 certification mandates

U.S. Army Reports Progress on COVID-19 Vaccine That Fights All Variants

0

Animal studies have already shown new vaccine induces highly potent antibody responses against major variants